If a similar role for the N protein and NF-kB is demonstrated for COVID-19 as for SARS in adults, then it is critical that new antiviral treatments are given early during the onset of disease to block the proinflammatory signals leading to cytokine storm. Here, NFKB1 is linked to severe acute respiratory syndrome.